Clinical Trial Update: A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide [NA]

View source ↗

Summary

This clinical trial update describes a study in HIV-1–infected adults to map virologic reservoirs at various antiretroviral concentrations in patients on a firs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)
• Bictegravir (bictegravir)
• Emtricitabine (Emtricitabine)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1-infection | NA | Status: NOT_YET_RECRUITING